Because metabolism is a complex balanced process involving multiple enzymes, understanding how 39 organisms compensate for transient or permanent metabolic imbalance is a challenging task that can be 40 more easily achieved in simpler unicellular organisms. The metabolic balance results from the 41 combination of individual enzymatic properties, regulation of enzyme abundance, but also from the 42 architecture of the metabolic network offering multiple interconversion alternatives. Although metabolic 43 networks are generally highly resilient to perturbations, metabolic imbalance resulting from enzymatic 44 defect and specific environmental conditions can be designed experimentally and studied. Starting with 45 a double amd1 aah1 mutant that severely and conditionally affects yeast growth, we carefully 46 characterized the metabolic shuffle associated with this defect. We established that the GTP decrease 47resulting in an adenylic/guanylic nucleotide imbalance was responsible for the growth defect.
48Identification of several gene dosage suppressors revealed that TAT1, encoding an amino acid 49 transporter, is a robust suppressor of the amd1 aah1 growth defect. We show that TAT1 suppression 50 occurs through replenishment of the GTP pool in a process requiring the histidine biosynthesis pathway. 51Importantly, we establish that a tat1 mutant exhibits synthetic-sickness when combined with an amd1 52 mutant and that both components of this synthetic phenotype can be suppressed by specific gene dosage 53 suppressors. Together our data point to a strong phenotypic connection between amino acid uptake and 54 GTP synthesis, a connection that could open perspectives for future treatment of related human defects, 55 previously reported as etiologically highly conserved.